New advances in leukaemia immunotherapy by the use of Chimeric Artificial Antigen Receptors (CARs): state of the art and perspectives for the near future

Leukaemia immunotherapy represents a fascinating and promising field of translational research, particularly as an integrative approach of bone marrow transplantation. Adoptive immunotherapy by the use of donor-derived expanded leukaemia-specific T cells has showed some kind of clinical response, bu...

Descripción completa

Detalles Bibliográficos
Autores principales: Biagi, Ettore, Marin, Virna, Attianese, Greta Maria Paola Giordano, Pizzitola, Irene, Tettamanti, Sarah, Cribioli, Elisabetta, Biondi, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195094/
https://www.ncbi.nlm.nih.gov/pubmed/21939556
http://dx.doi.org/10.1186/1824-7288-37-46

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195094/
https://www.ncbi.nlm.nih.gov/pubmed/21939556
http://dx.doi.org/10.1186/1824-7288-37-46

Ejemplares similares